Actility Launches ThingPark Approved Programme to Simplify and Accelerate IoT Solution Deployment
LoRa Alliance All Member Meeting, Munich: 21 July 2016
Actility, the industry leader in low power wide area networking, and the innovator behind the ThingPark LPWA IoT platform, today announces the launch of the “ThingPark Approved” programme, and welcomes its first partners to obtain the ThingPark Approved status. Covering the solution spectrum from sensors and modules to gateways and ultimately applications, ThingPark Approved products are evaluated across a range of interfaces and integration points to ensure interoperability within an end to end solution. Highlighting the diversity of partners in the ThingPark Ecosystem, Actility is delighted to announce ThingPark Approved status for Adeunis RF, AllThingsTalk, ATIM, Daliworks, Expemb, Finsecur, Flashnet, Foxconn, Globalsat, IMST, Kerlink, Microchip, MultiTech, MyDevices, Nemeus, NKE-Watteco, Omniimpex, Rising HF and Sensing Labs.
“One of the key challenges in making the IoT a global reality is to simplify the process of creating and deploying end to end solutions,“ says Actility Vice President for Ecosystem Christophe Francois. “Even today, there are thousands of potential solution components from hundreds of suppliers, the ecosystem is exploding. Open standards and certification programmes have a key role to play, but they address specific technology requirements. ThingPark Approved is a business enabler, not a certification programme. It allows partners in our ecosystem to feel confident that they can rely on interoperability with any other product or service found in the ThingPark Marketplace.”
“We are very proud to be approved by ThingPark and join this family.” comments Alpha Tsai, EVP of GlobalSat, “GlobalSat is among the very first LoRa adaptors in Asia. We have spent tremendous effort in promoting LoRa applications. Actility is our first choice network provider thanks to their reliability and instant support. We have gone through intensive interoperability testing to provide customers the easiest integration from end-node to application platform through the ThingPark environment.”
“It’s a great opportunity for Expemb to work with Actility, to master the unique challenges and opportunities offered by the industrial IoT,” adds Franck Priou, IoT & M2M Market Manager at Expemb. “We are delighted to offer our ThingPark Approved gateways, simple and scalable connection solutions which promote greater adoption of industrial IoT. We strive to better meet the needs of businesses to access their data, allowing them to focus on the development of their business applications.”
“By combining Actility ThingPark with myDevices’ Cayenne, the world’s first drag and drop IoT project builder, we have provided smart cities and enterprise customers with the ability to quickly prototype and deploy large-scale IoT projects,” explains Kevin Bromber, CEO myDevices. “This partnership will enable end customers to select from a growing list of LoRa sensors, motors and actuators that can be combined into a single project where remote monitoring, data visualization, triggered events and SMS/email notifications can be assembled and deployed for a variety of use cases.”
“We are pleased to be among the first ThingPark Approved gateway and module vendors for Actility LoRaWAN networks,” says Daniel Quant, Vice President of Product Management and Strategic Marketing at MultiTech. “With Actility software preloaded on our new Conduit LoRa Starter Kit, Actility and MultiTech make developing and deploying LoRaWAN-based IoT applications easier than ever.”
The ThingPark Approved Programme offers a complete business accelerator to fast-track IoT solutions to market. ThingPark partners can connect and test their products and achieve ThingPark Approved status, interact with other solution providers in the ThingPark ecosystem, and then market and sell their solutions in the ThingPark MarketPlace. The straightforward process will be managed through the ThingPark Partner website. ThingPark Approved partners will have opportunities to participate in co-marketing activity, and all will be able to display the ThingPark Approved logo on their products, collateral and web-sites. The ThingPark Partner web-site will be open for business early August, after completing its pilot phase. It will be accessible at: www.partners.thingpark.com
The ThingPark Approved programme is the latest step in the development of Actility’s ThingPark IoT solutions platform. Alongside ThingPark Marketplace, it also comprises the ThingPark Wireless LPWA network, and ThingPark Mash-up, an open API data mediation platform.
“The launch of the ThingPark Approved programme clearly demonstrates the growing maturity of the ThingPark ecosystem,” concludes Actility CEO Mike Mulica. “We’re delighted that such a diverse group of partners have stepped up to launch the programme and take advantage of the go-to-market acceleration that it delivers.”
About our new ThingPark Approved Partners
Actility Press contact
Anne van Gemert
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage22.2.2018 06:00 | Pressemelding
Ferring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative, today announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO). CHAMPION is investigating whether Ferring’s proprietary and heat-stable carbetocin could offer a new solution to prevent excessive bleeding after childbirth (postpartum haemorrhage or PPH).2,3 Involving nearly 30,000 women in 10 countries, it is the largest clinical trial ever conducted in PPH.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221006496/en/ Each year, 14 million mothers are affected by PPH.4 As the leading direct cause of maternal mortality, 480,000 mothers died from PPH between 2003-09.1 Even when women survive, PPH can result in the need for serious medical interventions, including surgica
The Nippon Foundation: Project to Map Ocean Floor by 2030 Now Operational22.2.2018 05:00 | Pressemelding
The Nippon Foundation Chairman Yohei Sasakawa announced at a press conference today that The Nippon Foundation – GEBCO Seabed 2030 Project is now operational. The Project will realize Mr. Sasakawa’s vision of mapping the entire ocean floor by 2030. The Nippon Foundation has pledged US$2 million annually, and is calling for additional support from the global ocean community. Mr. Sasakawa noted, “The Nippon Foundation alone cannot achieve the objectives of this ambitious project. We will need the support of diverse stakeholders, including maritime corporations and technical experts. It is crucial that the ocean community comes together to achieve this goal”. He was joined by leading ocean-mapping experts, who emphasized that understanding the bathymetry of the global ocean is imperative for improving maritime navigation, and also for enhancing our ability to predict climate change and monitor marine biodiversity and resources. A comprehensive map of the seafloor will assist global effort
Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis21.2.2018 21:01 | Pressemelding
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it is initiating the first Phase 3 study of VX-659, tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation. The study will enroll 360 patients, and the primary endpoint of the study is the mean absolute change from baseline in percent predicted forced expiratory volume in one second (ppFEV1) at week four of treatment. The study is designed to support the submission of a New Drug Application (NDA) in the U.S. using data from the 4-week primary efficacy endpoint together with safety data through 12 weeks of treatment. “Our goal is to bring the best triple combination to patients as rapidly as possible, and this first Phase 3 study of VX-659 in combination with tezacaftor and ivacaftor is a significant step toward that goal,” said Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical
Universal Laser Systems® Expands Portfolio of Laser Material Processing Systems with the ULTRA Platform Series21.2.2018 18:00 | Pressemelding
ULTRA platform-based laser systems are designed and ideally suited for precision laser cutting, laser ablation, and laser surface modification in manufacturing, research and development, academic research and prototyping environments. Major features of the series include rapid, high-accuracy laser beam positioning, and the flexibility to be configured with 9.3 and 10.6 µm CO2 lasers and 1.06 µm fiber lasers. All lasers are air-cooled in a range of power from 10 to 150 watts for CO2 and 40 to 50 watts for fiber lasers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005364/en/ The ULTRA 9MW offers MultiWave processing of thin materials. (Photo: Business Wire) The variety of wavelengths and power ranges make the ULTRA platforms highly effective in the areas of organic material modification, including plastic films, industrial fabrics, engineering plastics, laminating adhesives, composite materials, and many others utilized
Luxoft One of Six Companies Collaborating with Amazon Web Services to Accelerate Blockchain Adoption21.2.2018 16:30 | Pressemelding
Luxoft Holding Inc (NYSE:LXFT), a global IT service provider, announces today that it is collaborating with Amazon Web Services (AWS) to enable corporates to adopt blockchain and Distributed Ledger Technologies (DLT). Luxoft is one of six IT and consulting services companies to make its blockchain advisory and development services available to AWS users. “We are very excited to be working with AWS to help users engage with blockchain and DLTs,” said Vasiliy Suvorov, Vice President of Technology Strategy at Luxoft. “Blockchain is about removing data silos, improving trust and operational efficiencies. By using AWS to deploy and integrate DLTs into day-to-day processes, businesses can revolutionize how they operate.” Luxoft helps accelerate the deployment and integration of blockchain and DLT-based projects on AWS and is already working on a number of DLT projects using the cloud. For example, Luxoft is building a healthcare claims processing system for a leading healthcare provider usin
Westinghouse Electric Company to Provide Engineering Support at Vandellós 1 in Partnership with EDF21.2.2018 16:30 | Pressemelding
Westinghouse Electric Company and Electricité de France (EDF), in partnership, announced today that they have been awarded a contract from Empresa Nacional de Residuos Radiactivos (ENRESA), the Spanish agency responsible for radioactive waste management and nuclear plant decommissioning. The agreement covers a four-year engineering support contract for the latency phase of the dismantling and decommissioning project at Vandellós I Nuclear Power Station in Spain and includes the preparation of technical and licensing documentation. “We are extremely pleased that ENRESA has selected Westinghouse and EDF to continue supporting the decommissioning activities at Vandellós I Nuclear Power Station,” said Yves Brachet, Westinghouse vice president, Global Decommissioning, Decontamination, Remediation and Waste Management. “This contract further demonstrates Westinghouse’s global capabilities and expertise in providing innovative decommissioning solutions.” Sylvain Granger, head of EDF's decommi